CHI PHARMACEUTICAL SERVICES LTD

Company Registration Number:
14456037 (England and Wales)

Unaudited statutory accounts for the year ended 30 November 2023

Period of accounts

Start date: 01 November 2022

End date: 30 November 2023

CHI PHARMACEUTICAL SERVICES LTD

Contents of the Financial Statements

for the Period Ended 30 November 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 12

CHI PHARMACEUTICAL SERVICES LTD

Company Information

for the Period Ended 30 November 2023




Director: Chioma sandra nwosu
Registered office: 34
Chailey Avenue
Enfield
England
EN1 3LZ
Company Registration Number: 14456037 (England and Wales)

CHI PHARMACEUTICAL SERVICES LTD

Directors' Report Period Ended 30 November 2023

The directors present their report with the financial statements of the company for the period ended 30 November 2023

Principal Activities

Provision of pharmaceutical support services

Directors

The director(s) shown below were appointed to the company during the period
Chioma sandra nwosu
01 November 2022

This report was approved by the board of directors on 31 May 2024
And Signed On Behalf Of The Board By:

Name: Chioma sandra nwosu
Status: Director

CHI PHARMACEUTICAL SERVICES LTD

Profit and Loss Account

for the Period Ended 30 November 2023


Notes
13 months to
30 Nov 2023
£
Turnover 38,898
Gross Profit or (Loss) 38,898
Administrative Expenses ( 28,298 )
Operating Profit or (Loss) 10,600
Profit or (Loss) Before Tax 10,600
Tax on Profit ( 2,014 )
Profit or (Loss) for Period 8,586

The notes form part of these financial statements

CHI PHARMACEUTICAL SERVICES LTD

Balance sheet

As at 30 November 2023


Notes
13 months to
30 Nov 2023
£
Fixed assets
Total fixed assets: -
Current assets
Debtors: 5 1,370
Cash at bank and in hand: 3,611
Total current assets: 4,981
Prepayments and accrued income: 3,600
Creditors: amounts falling due within one year: 6 ( 2,014 )
Net current assets (liabilities): 6,567
Total assets less current liabilities: 6,567
Total net assets (liabilities): 6,567

The notes form part of these financial statements

CHI PHARMACEUTICAL SERVICES LTD

Balance sheet continued

As at 30 November 2023


Notes
13 months to
30 Nov 2023
£
Capital and reserves
Called up share capital: 1
Profit and loss account: 6,566
Shareholders funds: 6,567

For the year ending 30 November 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 31 May 2024
And Signed On Behalf Of The Board By:

Name: Chioma sandra nwosu
Status: Director

The notes form part of these financial statements

CHI PHARMACEUTICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 30 November 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CHI PHARMACEUTICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 30 November 2023

  • 2. Employees

    13 months to
    30 Nov 2023
    Average number of employees during the period 1

CHI PHARMACEUTICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 30 November 2023

  • 3. Off balance sheet disclosure

    No

CHI PHARMACEUTICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 30 November 2023

4. Dividends

13 months to
30 Nov 2023
£
Dividends paid 2,000

CHI PHARMACEUTICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 30 November 2023

5. Debtors

13 months to
30 Nov 2023
£
Other debtors 1,370
Total 1,370

CHI PHARMACEUTICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 30 November 2023

6.Creditors: amounts falling due within one year note

13 months to
30 Nov 2023
£
Taxation and social security 2,014
Total 2,014